UTS Research Centre

Australian Institute for Microbiology & Infection (AIMI)

PEOPLE

    • Visiting Fellow
    • Australian Inst Microbiology and Infection (AIMI)
    • Visiting FellowAustralian Inst Microbiology and Infection (AIMI)
    • Academic
    Disciplines
    • Immunology
    • Microbiology
    • Veterinary sciences
    • Visiting Fellow
    • Australian Inst Microbiology and Infection (AIMI)
    • Visiting FellowAustralian Inst Microbiology and Infection (AIMI)

    Dr Barbara Brito Rodriguez is a UTS Visiting Fellow and Veterinary Research Officer NSW DPI (Biosecurity & Food Safety).  

    She is interested in supporting the design of animal disease control measures and surveillance using the results of scientific studies. Her research areas are quantitative epidemiology, animal disease modeling, and molecular epidemiology (pathogen genetics) of infectious animal diseases. She is also interested developing advanced skills in epidemiology, statistics, and sequence data analysis, with particular focus in metagenomics.

    Dr Barbara Brito Rodriguez is a UTS Visiting Fellow and Veterinary Research Officer NSW DPI (Biosecurity & Food Safety).  

    She is interested in supporting the design of animal disease control measures and surveillance using the results of scientific studies. Her research areas are quantitative epidemiology, animal disease modeling, and molecular epidemiology (pathogen genetics) of infectious animal diseases. She is also interested developing advanced skills in epidemiology, statistics, and sequence data analysis, with particular focus in metagenomics.

    • Academic
    • Masters Research or PhD student supervision
    Disciplines
    • Microbial genetics
    • Veterinary diagnosis and diagnostics
    • Veterinary virology
    • Associate Professor
    • Molecular Biotechnology Discipline
    • Associate ProfessorMolecular Biotechnology Discipline

    Andrew is an Associate Professor and Academic Director of the Biologics Innovation Facility (BIF) within the School of Life Sciences at UTS. His research innovatively combines synthetic biology and nanomedicine to re-engineer biologically-derived nanoparticles for drug delivery and vaccines. He holds a PhD in Chemistry and Biomolecular Sciences from Macquarie University and has previously held independent research fellowships - Cancer Institute NSW Early Career Fellowship and UTS Chancellor's Research Fellowship. Andrew engages actively with industry, was a Chief Investigator in the ARC ITRC IDEAL Hub, and received the UTS Vice-Chancellor’s Award for Research Excellence through Collaboration and Partnership for work with the hub.

    Andrew's teaching and learning philosophy focusses on active student engagement, particularly through immersive research experiences. He has experience in whole curricula development as a Postgraduate Program Director in the Faculty of Science and has been recognized for incorporating a Work Integrated Learning (WIL) approach into his teaching. Andrew also established and coordinated UTS teams participating in the inter-university Australasian Synthetic Biology Challenge, leading to the creation of the science-meets-design magazine SYNTHESIS. Andrew’s ongoing commitment to quality higher education and innovative learning has earned him a UTS Vice-Chancellor’s T&L Citation and multiple UTS Faculty of Science Dean’s Awards.

    As the Academic Director of the Biologics Innovation Facility (BIF), Andrew is passionate about providing high-quality teaching and training to students and professionals, equipping them with advanced knowledge and hands-on skills for immediate entry into the rapidly expanding biomanufacturing sector.

    Andrew is an Associate Professor and Academic Director of the Biologics Innovation Facility (BIF) within the School of Life Sciences at UTS. His research innovatively combines synthetic biology and nanomedicine to re-engineer biologically-derived nanoparticles for drug delivery and vaccines. He holds a PhD in Chemistry and Biomolecular Sciences from Macquarie University and has previously held independent research fellowships - Cancer Institute NSW Early Career Fellowship and UTS Chancellor's Research Fellowship. Andrew engages actively with industry, was a Chief Investigator in the ARC ITRC IDEAL Hub, and received the UTS Vice-Chancellor’s Award for Research Excellence through Collaboration and Partnership for work with the hub.

    Andrew's teaching and learning philosophy focusses on active student engagement, particularly through immersive research experiences. He has experience in whole curricula development as a Postgraduate Program Director in the Faculty of Science and has been recognized for incorporating a Work Integrated Learning (WIL) approach into his teaching. Andrew also established and coordinated UTS teams participating in the inter-university Australasian Synthetic Biology Challenge, leading to the creation of the science-meets-design magazine SYNTHESIS. Andrew’s ongoing commitment to quality higher education and innovative learning has earned him a UTS Vice-Chancellor’s T&L Citation and multiple UTS Faculty of Science Dean’s Awards.

    As the Academic Director of the Biologics Innovation Facility (BIF), Andrew is passionate about providing high-quality teaching and training to students and professionals, equipping them with advanced knowledge and hands-on skills for immediate entry into the rapidly expanding biomanufacturing sector.

    • Academic
    • Masters Research or PhD student supervision
    • Media enquiries
    • Industry Projects
    • Collaborative projects
    Disciplines
    • Synthetic biology
    • Nanomedicine
    • Nanobiotechnology
    • Bioprocessing, bioproduction and bioproducts
    • Visiting Fellow
    • Australian Inst Microbiology and Infection (AIMI)
    • Visiting FellowAustralian Inst Microbiology and Infection (AIMI)

    Nural is the Faculty Research Engagement Manager for the Faculty of Science, and part of the central Research Office team. In the Faculty, she is a member of the Partnerships team who manage all business development, commercialisation, and industry and other external engagement activities. Nural's role focuses on diversifying research funding and opportunities for the Faculty, and facilitating research collaborations and engagements with internal and external stakeholders.

    Nural has a PhD in microbiology, where her research has focused on the relationship between bees, the environment and medicinal honey. She leads research on the bioactive properties of honey, specifically into its use as a topical treatment for infections caused by antibiotic resistant superbugs and as a prebiotic food to promote a healthy gut microbiome.

    Nural is recognised as a global leader in medicinal honey and bee research and has extensive experience in leading and delivering industry-driven research programs, as well as working in tertiary education, industry and external stakeholder engagement, project management, strategic planning, and reporting and presenting to a wide range of audiences. She uses her strong relationship building and science communication skills to develop collaborative, strategic and impactful partnerships and opportunities. She has demonstrated success with working in small and large teams and in collaboration with stakeholders from academia, industry and government on projects that use excellent science and translational research to drive positive changes. 

    Nural is the Faculty Research Engagement Manager for the Faculty of Science, and part of the central Research Office team. In the Faculty, she is a member of the Partnerships team who manage all business development, commercialisation, and industry and other external engagement activities. Nural's role focuses on diversifying research funding and opportunities for the Faculty, and facilitating research collaborations and engagements with internal and external stakeholders.

    Nural has a PhD in microbiology, where her research has focused on the relationship between bees, the environment and medicinal honey. She leads research on the bioactive properties of honey, specifically into its use as a topical treatment for infections caused by antibiotic resistant superbugs and as a prebiotic food to promote a healthy gut microbiome.

    Nural is recognised as a global leader in medicinal honey and bee research and has extensive experience in leading and delivering industry-driven research programs, as well as working in tertiary education, industry and external stakeholder engagement, project management, strategic planning, and reporting and presenting to a wide range of audiences. She uses her strong relationship building and science communication skills to develop collaborative, strategic and impactful partnerships and opportunities. She has demonstrated success with working in small and large teams and in collaboration with stakeholders from academia, industry and government on projects that use excellent science and translational research to drive positive changes. 

    • Academic
    • Collaborative projects
    • Industry Projects
    • Media enquiries
    Disciplines
    • Microbiology
    • Contractor
    • Faculty of Science
    • ContractorFaculty of Science
    Aaron Darling is a Visiting Professor. He was a Professor in Computational Genomics and Bioinformatics in the UTS Faculty of Science ithree institute. He has over a decade of experience developing computational methods for comparative genomics and evolutionary modeling and in 2013 moved from the University of California-Davis to start a computational genomics group at UTS.

    Darling embarked on his research career at the University of Wisconsin-Madison. Following a bachelor degree in Computer Science, he worked with members of the UW-Madison Genome Center to sequence and analyze the first genomes of pathogenic E. coli. During this time Darling led the development of some widely used computational methods for analysing genomic data, including the mpiBLAST open source parallel BLAST software and the Mauve software for comparing multiple genome sequences.

    Following the award of a Ph.D. at UW-Madison, Darling received a fellowship from the US National Science Foundation to pursue postdoctoral studies at The University of Queensland. After two years at UQ he then returned to UC Davis to develop a research program in computational metagenomics -- the study of uncultivated microorganisms from the environment using computational methods.

    Darling now brings his experience to understand the relationship between humans and microorganisms in collaboration with microbiologists at the ithree institute.
    Aaron Darling is a Visiting Professor. He was a Professor in Computational Genomics and Bioinformatics in the UTS Faculty of Science ithree institute. He has over a decade of experience developing computational methods for comparative genomics and evolutionary modeling and in 2013 moved from the University of California-Davis to start a computational genomics group at UTS.

    Darling embarked on his research career at the University of Wisconsin-Madison. Following a bachelor degree in Computer Science, he worked with members of the UW-Madison Genome Center to sequence and analyze the first genomes of pathogenic E. coli. During this time Darling led the development of some widely used computational methods for analysing genomic data, including the mpiBLAST open source parallel BLAST software and the Mauve software for comparing multiple genome sequences.

    Following the award of a Ph.D. at UW-Madison, Darling received a fellowship from the US National Science Foundation to pursue postdoctoral studies at The University of Queensland. After two years at UQ he then returned to UC Davis to develop a research program in computational metagenomics -- the study of uncultivated microorganisms from the environment using computational methods.

    Darling now brings his experience to understand the relationship between humans and microorganisms in collaboration with microbiologists at the ithree institute.
    • Professional
    • Masters Research or PhD student supervision
    Disciplines
    • Genetics
    • Microbiology
    • Veterinary sciences
    • Distinguished Professor
    • Medical Science Discipline
    • Distinguished ProfessorMedical Science Discipline

    Steven Djordjevic is Professor of Infectious Disease and Group Leader in the Australian Institute for Microbiology & Infection at the University of Technology Sydney. Professor Djordjevic’s research generates and interrogates genomic and proteomics data to mitigate against AMR, understand pathogen evolution and to identify and characterize novel antigens for vaccine development. Professor Djordjevic is a cofounder and a member of the governing board and the scientific management committee of Ausgem, the Australian Centre for Genomic Epidemiological Microbiology, a collaborative partnership with the NSW Department of Primary Industries. Phylogenomics and molecular epidemiology are the tools we use to study antibiotic resistance and bacterial pathogenesis and to shed light on how established and emerging pathogenic bacteria and the mobile elements they carry, evolve and circulate in clinical, livestock, agricultural, wastewater and aquatic environments - A One Health/One Planet Approach. His group also has a focus on the molecular, structural and biochemical characterisation of bacterial molecules that function in adherence, colonisation and invasion of eukaryote cells and a strong interest in the roles of protein processing and protein multifunctionality in bacterial pathogenesis.

    Steven Djordjevic is Professor of Infectious Disease and Group Leader in the Australian Institute for Microbiology & Infection at the University of Technology Sydney. Professor Djordjevic’s research generates and interrogates genomic and proteomics data to mitigate against AMR, understand pathogen evolution and to identify and characterize novel antigens for vaccine development. Professor Djordjevic is a cofounder and a member of the governing board and the scientific management committee of Ausgem, the Australian Centre for Genomic Epidemiological Microbiology, a collaborative partnership with the NSW Department of Primary Industries. Phylogenomics and molecular epidemiology are the tools we use to study antibiotic resistance and bacterial pathogenesis and to shed light on how established and emerging pathogenic bacteria and the mobile elements they carry, evolve and circulate in clinical, livestock, agricultural, wastewater and aquatic environments - A One Health/One Planet Approach. His group also has a focus on the molecular, structural and biochemical characterisation of bacterial molecules that function in adherence, colonisation and invasion of eukaryote cells and a strong interest in the roles of protein processing and protein multifunctionality in bacterial pathogenesis.

    • Academic
    • Media enquiries
    • Masters Research or PhD student supervision
    Disciplines
    • Immunology
    • Microbiology
    • Veterinary sciences
  • Head
    Administrator
    Director
    Contact
    • Director, AIMI
    • Australian Inst Microbiology and Infection (AIMI)
    • Director, AIMIAustralian Inst Microbiology and Infection (AIMI)

    Iain Duggin is Professor of Molecular Microbiology and Biotechnology, and is the Director of the Australian Institute for Microbiology and Infection (AIMI).

     

    In AIMI, Iain leads the Microbial Morphology and Development (MMD) research theme. Our research aims to understand microbial 'shapeshifting' at the cellular, molecular and evolutionary levels. We use comparative biology approaches to understanding the mechanisms and evolution of microbial cell morphodynamics and division; by identifying and comparing these cellular functions across the tree of life - in model archaea and bacteria - common mechanisms and principles can be identified and appreciated from an evolutionary perspective, leading to useful applications and a better understanding of life's history and future. By using this knowledge and associated technology in molecular and cellular biology, Iain's team also work intensively on biotechnology to address the growing problems of climate change (microbial emissions mitigation) and infectious disease (Urinary Tract Infection, Antimicrobial Resistance).

    Prof Duggin obtained his PhD in Molecular Biology from The University of Sydney in 2002 and pursued postdoctoral research at the University of Sydney (2002-2004) before being awarded a MRC Career Development Fellowship at the MRC Cancer Cell Unit, Cambridge, UK and then at the Sir William Dunn School of Pathology, University of Oxford, (2005-2009). He was a research associate at the MRC Laboratory of Molecular Biology (LMB), Cambridge UK (2009-2011), before his recruitment to the UTS iThree institute (renamed AIMI in 2022) as a research fellow in 2011. He was awarded an Australian Research Council (ARC) Future Fellowship (2017-2020), and has been awarded research grants from national research agencies including the ARC, NSW Health, and the Medical Research Future Fund (MRFF), as well as through industry partnerships.

    Iain Duggin is Professor of Molecular Microbiology and Biotechnology, and is the Director of the Australian Institute for Microbiology and Infection (AIMI).

     

    In AIMI, Iain leads the Microbial Morphology and Development (MMD) research theme. Our research aims to understand microbial 'shapeshifting' at the cellular, molecular and evolutionary levels. We use comparative biology approaches to understanding the mechanisms and evolution of microbial cell morphodynamics and division; by identifying and comparing these cellular functions across the tree of life - in model archaea and bacteria - common mechanisms and principles can be identified and appreciated from an evolutionary perspective, leading to useful applications and a better understanding of life's history and future. By using this knowledge and associated technology in molecular and cellular biology, Iain's team also work intensively on biotechnology to address the growing problems of climate change (microbial emissions mitigation) and infectious disease (Urinary Tract Infection, Antimicrobial Resistance).

    Prof Duggin obtained his PhD in Molecular Biology from The University of Sydney in 2002 and pursued postdoctoral research at the University of Sydney (2002-2004) before being awarded a MRC Career Development Fellowship at the MRC Cancer Cell Unit, Cambridge, UK and then at the Sir William Dunn School of Pathology, University of Oxford, (2005-2009). He was a research associate at the MRC Laboratory of Molecular Biology (LMB), Cambridge UK (2009-2011), before his recruitment to the UTS iThree institute (renamed AIMI in 2022) as a research fellow in 2011. He was awarded an Australian Research Council (ARC) Future Fellowship (2017-2020), and has been awarded research grants from national research agencies including the ARC, NSW Health, and the Medical Research Future Fund (MRFF), as well as through industry partnerships.

    • 3 Good Health and Well Being
    • 13 Climate Action
    • Academic
    • Media enquiries
    • Masters Research or PhD student supervision
    • Collaborative projects
    • Industry Projects
    • Membership of an advisory committee
    Disciplines
    • Microbiology
    • DECRA Fellow
    • Medical Science Discipline
    • DECRA FellowMedical Science Discipline

    Dr Gustavo Espinoza-Vergara is an ARC DECRA Fellow at the Australian Institute for Microbiology & Infection (AIMI), University of Technology Sydney. His research focuses on the mechanisms that underpin bacterial stress responses, with particular interest in how interactions with higher organisms influence pathogen survival, persistence in the environment, and virulence in the host.

     

    During his PhD, Dr Espinoza-Vergara undertook advanced training in molecular biology and mouse models at two leading laboratories in the United States. His research work has been recognised with the Dean’s Award for Outstanding PhD Thesis (UNSW, 2019), a conference award from the American Society for Microbiology (Washington DC), and postgraduate scholarships from UNSW (2016–2017).


    Dr Espinoza-Vergara has successfully supervised HDRs to completion and currently supervises PhD and Honours candidates. Since 2014, he has been awarded several prestigious fellowships, including a Doctoral Fellowship (155K, Chile), the AIMI Path Fellowship (250K, 2024), and the highly competitive ARC DECRA Fellowship ($432K, 2024). In addition to securing smaller research grants as Chief Investigator (~$55K), his work contributed significantly to the success of an ARC Discovery Project (DP170100453, $516K). His research has been presented at five international conferences in Vibrio biology and Microbial Ecology.

    Dr Espinoza-Vergara made a groundbreaking discovery identifying a novel class of bacterial transmission vectors—protozoan expelled food vacuoles (EFVs)—that enhance pathogen virulence in the host. This work has been recognised by international experts in Vibrio cholerae research and was featured in nine major news stories. In 2021, he was awarded one of Australia’s most prestigious scientific awards: the Eureka Prize for Scientific Research, for his pioneering work on novel vectors of gut infectious agents.

    Dr Gustavo Espinoza-Vergara is an ARC DECRA Fellow at the Australian Institute for Microbiology & Infection (AIMI), University of Technology Sydney. His research focuses on the mechanisms that underpin bacterial stress responses, with particular interest in how interactions with higher organisms influence pathogen survival, persistence in the environment, and virulence in the host.

     

    During his PhD, Dr Espinoza-Vergara undertook advanced training in molecular biology and mouse models at two leading laboratories in the United States. His research work has been recognised with the Dean’s Award for Outstanding PhD Thesis (UNSW, 2019), a conference award from the American Society for Microbiology (Washington DC), and postgraduate scholarships from UNSW (2016–2017).


    Dr Espinoza-Vergara has successfully supervised HDRs to completion and currently supervises PhD and Honours candidates. Since 2014, he has been awarded several prestigious fellowships, including a Doctoral Fellowship (155K, Chile), the AIMI Path Fellowship (250K, 2024), and the highly competitive ARC DECRA Fellowship ($432K, 2024). In addition to securing smaller research grants as Chief Investigator (~$55K), his work contributed significantly to the success of an ARC Discovery Project (DP170100453, $516K). His research has been presented at five international conferences in Vibrio biology and Microbial Ecology.

    Dr Espinoza-Vergara made a groundbreaking discovery identifying a novel class of bacterial transmission vectors—protozoan expelled food vacuoles (EFVs)—that enhance pathogen virulence in the host. This work has been recognised by international experts in Vibrio cholerae research and was featured in nine major news stories. In 2021, he was awarded one of Australia’s most prestigious scientific awards: the Eureka Prize for Scientific Research, for his pioneering work on novel vectors of gut infectious agents.

    • Academic
    Disciplines
    • Microbiology
    • Visiting Fellow
    • Australian Inst Microbiology and Infection (AIMI)
    • Visiting FellowAustralian Inst Microbiology and Infection (AIMI)
    I'm a data scientist in the ithree institute with an interest in understanding the evolutionary processes that drive the evolution of pathogens.I develop phylogenetic algorithms and software to investigate natural selection, evolutionary rates, and the geographic dispersal of viruses such as influenza virus and HIV. My research is part of a bigger picture looking at ways to better manage global issues such as antimicrobial resistance and infectious disease outbreaks.
    I'm a data scientist in the ithree institute with an interest in understanding the evolutionary processes that drive the evolution of pathogens.I develop phylogenetic algorithms and software to investigate natural selection, evolutionary rates, and the geographic dispersal of viruses such as influenza virus and HIV. My research is part of a bigger picture looking at ways to better manage global issues such as antimicrobial resistance and infectious disease outbreaks.
    • Academic
    • Masters Research or PhD student supervision
    Disciplines
    • Biochemistry and cell biology
    • Clinical sciences
    • Virology
    • Associate Professor
    • Molecular Biotechnology Discipline
    • Associate ProfessorMolecular Biotechnology Discipline

    Cindy Gunawan is an Associate Professor of Microbiology and Nanomaterial Engineering at the Australian Institute for Microbiology and Infection (AIMI), 

     

    A/Prof Cindy Gunawan is a microbiologist, with expertise at the interface of microbiology, cellular biology and nanomaterial engineering. She joined UTS as a Chancellor's Research Fellow (CRF) (2015-2018) and now leads the Biofunctional Nanomaterials Research Group in AIMI. Her group focuses on the challenges of antimicrobial resistance (AMR), seeking to understand at molecular levels how bacterial pathogens evolve adaptive resistance to multi-targeting antimicrobials, including nanoparticles, and to develop technologies to overcome the phenomena. Gunawan also contributes to the development of smart nanoparticle antimicrobials and therapeutics as well as in studies of environmental AMR and human health impact of particulate matter. 

    The pioneering research have resulted in publications in prestigious journals, including Small, ACS Nano and Biomaterials, as well as being featured in Nature Nanotechnology as Research Highlights. Gunawan's team discovered the phenomena of bacterial resistance to nanosilver, one of the most developed and commercialized antimicrobial nanoparticles. The workhas featured in scientific and public media outlets, including the ARC (http://www.arc.gov.au/news-media/news/resilient-bacteria-adapt-nanosilver). The team further highlights the genuine potential of the current indiscriminate use of nanosilver to facilitate resistance development and its spread, calling for judicial and effectively regulated use of the nanoparticle. Gunawan has attracted over AUD 1.6 millions in research grants and fellowship, including ARC Discovery Projects (2018-2021, 2022-2026) and Australian Academy of Science (2020-2021) fundings as Lead CI.

    Gunawan received her Bachelor of Engineering in Bioprocess Engineering (Honours Class I and The University Medal, UNSW Sydney) in 2002. Awarded with The International Postgraduate Research Scholarship (IPRS), she pursued her PhD in Biotechnology (UNSW), developing an efficient biotransformation system for production of pharmaceutical precursor, which was completed in 2006. In 2008-2014, Dr Gunawan joined the Particle and Catalysis Research Group as Postdoctoral in the School of Chemical Engineering, UNSW.

    Cindy Gunawan is an Associate Professor of Microbiology and Nanomaterial Engineering at the Australian Institute for Microbiology and Infection (AIMI), 

     

    A/Prof Cindy Gunawan is a microbiologist, with expertise at the interface of microbiology, cellular biology and nanomaterial engineering. She joined UTS as a Chancellor's Research Fellow (CRF) (2015-2018) and now leads the Biofunctional Nanomaterials Research Group in AIMI. Her group focuses on the challenges of antimicrobial resistance (AMR), seeking to understand at molecular levels how bacterial pathogens evolve adaptive resistance to multi-targeting antimicrobials, including nanoparticles, and to develop technologies to overcome the phenomena. Gunawan also contributes to the development of smart nanoparticle antimicrobials and therapeutics as well as in studies of environmental AMR and human health impact of particulate matter. 

    The pioneering research have resulted in publications in prestigious journals, including Small, ACS Nano and Biomaterials, as well as being featured in Nature Nanotechnology as Research Highlights. Gunawan's team discovered the phenomena of bacterial resistance to nanosilver, one of the most developed and commercialized antimicrobial nanoparticles. The workhas featured in scientific and public media outlets, including the ARC (http://www.arc.gov.au/news-media/news/resilient-bacteria-adapt-nanosilver). The team further highlights the genuine potential of the current indiscriminate use of nanosilver to facilitate resistance development and its spread, calling for judicial and effectively regulated use of the nanoparticle. Gunawan has attracted over AUD 1.6 millions in research grants and fellowship, including ARC Discovery Projects (2018-2021, 2022-2026) and Australian Academy of Science (2020-2021) fundings as Lead CI.

    Gunawan received her Bachelor of Engineering in Bioprocess Engineering (Honours Class I and The University Medal, UNSW Sydney) in 2002. Awarded with The International Postgraduate Research Scholarship (IPRS), she pursued her PhD in Biotechnology (UNSW), developing an efficient biotransformation system for production of pharmaceutical precursor, which was completed in 2006. In 2008-2014, Dr Gunawan joined the Particle and Catalysis Research Group as Postdoctoral in the School of Chemical Engineering, UNSW.

    • Academic
    • Collaborative projects
    • Join a web conference as a panellist or speaker
    • Media enquiries
    • Masters Research or PhD student supervision
    Disciplines
    • Microbiology
    • Nanotechnology
    • Associate Professor
    • Medical Science Discipline
    • Associate ProfessorMedical Science Discipline

    Associate Professor Mehrad Hamidian is a microbiologist at the Australian Institute for Microbiology and Infection (AIMI) at UTS. His research focuses on characterising genomic regions that carry antibiotic-resistant genes in Acinetobacter baumannii, a bacterium that causes a range of hospital-acquired infections. 
    Mehrad holds an MSc in Medical Microbiology from the Tehran University of Medical Sciences and obtained his PhD in Microbiology in 2014 at the University of Sydney. He completed a Graduate Certificate Degree in Educational Studies (Higher Education) in 2015 at the University of Sydney.
    Receiving a UTS Chancellor's Research Fellowship in 2018, Mehrad moved to UTS to establish his independent research group studying various aspects of antibiotic resistance in A. baumannii. In 2019, in recognition of his work on antimicrobial resistance (AMR), he was honoured with the prestigious Australian Society for Microbiology (ASM) Jim Pittard Early-Career Award. Mehrad received an ARC DECRA fellowship to study A. baumannii plasmids in 2020.
    Mehrad’s pioneering discoveries have resulted in over 70 publications, and he engages regularly with national and international collaborators. He also led the development of the world’s first online database and plasmid typing scheme for A. baumannii.
    Outside of his academic work, Mehrad has made an increasing number of contributions to the research community and demonstrated his growing capacity in professional leadership.
    Mehrad has given invited presentations at national and international conferences, which include a symposium talk at the ASM Annual General Meeting in Sydney in 2022. In the same year, he also served on the 2022 international Acinetobacter conference scientific committee.
    Incredibly passionate about his work, Mehrad’s ultimate aim is to find ways to understand underlying resistance mechanisms to improve tracking, surveillance, and limit the spread of bacterial drug resistance in opportunistic pathogens.

    Associate Professor Mehrad Hamidian is a microbiologist at the Australian Institute for Microbiology and Infection (AIMI) at UTS. His research focuses on characterising genomic regions that carry antibiotic-resistant genes in Acinetobacter baumannii, a bacterium that causes a range of hospital-acquired infections. 
    Mehrad holds an MSc in Medical Microbiology from the Tehran University of Medical Sciences and obtained his PhD in Microbiology in 2014 at the University of Sydney. He completed a Graduate Certificate Degree in Educational Studies (Higher Education) in 2015 at the University of Sydney.
    Receiving a UTS Chancellor's Research Fellowship in 2018, Mehrad moved to UTS to establish his independent research group studying various aspects of antibiotic resistance in A. baumannii. In 2019, in recognition of his work on antimicrobial resistance (AMR), he was honoured with the prestigious Australian Society for Microbiology (ASM) Jim Pittard Early-Career Award. Mehrad received an ARC DECRA fellowship to study A. baumannii plasmids in 2020.
    Mehrad’s pioneering discoveries have resulted in over 70 publications, and he engages regularly with national and international collaborators. He also led the development of the world’s first online database and plasmid typing scheme for A. baumannii.
    Outside of his academic work, Mehrad has made an increasing number of contributions to the research community and demonstrated his growing capacity in professional leadership.
    Mehrad has given invited presentations at national and international conferences, which include a symposium talk at the ASM Annual General Meeting in Sydney in 2022. In the same year, he also served on the 2022 international Acinetobacter conference scientific committee.
    Incredibly passionate about his work, Mehrad’s ultimate aim is to find ways to understand underlying resistance mechanisms to improve tracking, surveillance, and limit the spread of bacterial drug resistance in opportunistic pathogens.

    • Academic
    • Masters Research or PhD student supervision
    Disciplines
    • Bioinformatics and computational biology
    • Microbiology
    • Emeritus Professor
    • Faculty of Science
    • Emeritus ProfessorFaculty of Science
    Liz Harry is an Emeritus Professor at UTS. A fascination with how bacterial cells multiply underpinned her pioneering research, which has changed the direction of thinking in this field of bacteriology. Liz values the translation of research for public good and she has worked with industry and government in antibiotic discovery and in the use of natural products as effective therapeutics for infectious disease.

    Liz has been awarded a series of research fellowships over her career, including a US NIH Fogarty International Fellowship to work at Harvard, and two Australian Research Council Fellowships at the University of Sydney. She moved to UTS in 2005. In recognition of her distinguished research contributions she was awarded the 2008 Frank Fenner Award (Australian Society for Microbiology) and received the 2002 Australian Eureka Prize for Scientific Research. In 2016 she was included in the SBS list of six impressive Aussie women scientists. Liz is a Fellow of the Australian Society for Microbiology.

    Liz has vast experience and knowledge of the development of successful ARC grants and Fellowships, NHMRC and government grants, having been continuously funded throughout her research career. She has worked with industry and negotiated successful partnerships across academic, industry and government sectors.

    Liz has served on several assessment, review and advisory panels in industry and academia, including assessment of investment proposals for research commercialisation. She has held several leadership and Chair positions within university and outside. She was Director of the ithree institute at UTS (2015-2019) and was the first chair of the UTS Prizes and Awards Advisory Committee, to develop a ‘Prizes R Us’ culture and provide strategic support for potential award candidates.

    Liz is strategic and creative in how she leads and has skills in communication, openness and in facilitating the development of a desired culture within a team that allows each person to be ‘dressed for success’.

    She has mentored several young academics to outstanding success and professional fulfilment. Her aim is to inspire them, grow their confidence and provide the advice that they need to achieve their goals and maintain wellbeing in this changing and challenging environment.
    Liz Harry is an Emeritus Professor at UTS. A fascination with how bacterial cells multiply underpinned her pioneering research, which has changed the direction of thinking in this field of bacteriology. Liz values the translation of research for public good and she has worked with industry and government in antibiotic discovery and in the use of natural products as effective therapeutics for infectious disease.

    Liz has been awarded a series of research fellowships over her career, including a US NIH Fogarty International Fellowship to work at Harvard, and two Australian Research Council Fellowships at the University of Sydney. She moved to UTS in 2005. In recognition of her distinguished research contributions she was awarded the 2008 Frank Fenner Award (Australian Society for Microbiology) and received the 2002 Australian Eureka Prize for Scientific Research. In 2016 she was included in the SBS list of six impressive Aussie women scientists. Liz is a Fellow of the Australian Society for Microbiology.

    Liz has vast experience and knowledge of the development of successful ARC grants and Fellowships, NHMRC and government grants, having been continuously funded throughout her research career. She has worked with industry and negotiated successful partnerships across academic, industry and government sectors.

    Liz has served on several assessment, review and advisory panels in industry and academia, including assessment of investment proposals for research commercialisation. She has held several leadership and Chair positions within university and outside. She was Director of the ithree institute at UTS (2015-2019) and was the first chair of the UTS Prizes and Awards Advisory Committee, to develop a ‘Prizes R Us’ culture and provide strategic support for potential award candidates.

    Liz is strategic and creative in how she leads and has skills in communication, openness and in facilitating the development of a desired culture within a team that allows each person to be ‘dressed for success’.

    She has mentored several young academics to outstanding success and professional fulfilment. Her aim is to inspire them, grow their confidence and provide the advice that they need to achieve their goals and maintain wellbeing in this changing and challenging environment.
    • Academic
    • Masters Research or PhD student supervision
    Disciplines
    • Medical biochemistry and metabolomics
    • Microbiology
    • Research Fellow
    • Medical Science Discipline
    • Research FellowMedical Science Discipline

    Veronica Jarocki is a Research Fellow at the Australian Institute for Microbiology and Infection and Foundational Postdoctoral Fellow at SAAFE CRC. She’s focused on microbial genomics, with a background in proteomics and subunit vaccine development. Having worked as a registered nurse for more than 11 years while subsequently pursuing biological and biomedical sciences, Veronica brings a unique lens to the growing issue of antimicrobial resistance (AMR).

    Through her research, Veronica is keenly focused on identifying AMR hotspots – equipping us with robust information about where resistance occurs and the rate at which it develops. She understands that a pivotal aspect of tackling AMR head on is first understanding where the issue is most concentrated.

    Veronica was first exposed to the threats posed by AMR during her PhD. While identifying potential vaccine candidates against a pig pathogen, she became acutely cognisant of AMR’s growing health and economic burden in the animal, environmental and human sectors. Eager to get a better grasp on what is an incredibly complex issue, she subsequently moved into genomics.

    Veronica works closely with our industry partners to develop PhD programs focused on broadening our understanding of AMR transmission dynamics. She also spends her days analysing vast collections of whole genome sequences, which have been derived from environmental and animal-associated bacteria – mainly E. coli. More specifically, she’s hard at work investigating the relationships between bacteria from different sources and the mechanisms that drive antimicrobial resistance and pathogen evolution.

    Veronica Jarocki is a Research Fellow at the Australian Institute for Microbiology and Infection and Foundational Postdoctoral Fellow at SAAFE CRC. She’s focused on microbial genomics, with a background in proteomics and subunit vaccine development. Having worked as a registered nurse for more than 11 years while subsequently pursuing biological and biomedical sciences, Veronica brings a unique lens to the growing issue of antimicrobial resistance (AMR).

    Through her research, Veronica is keenly focused on identifying AMR hotspots – equipping us with robust information about where resistance occurs and the rate at which it develops. She understands that a pivotal aspect of tackling AMR head on is first understanding where the issue is most concentrated.

    Veronica was first exposed to the threats posed by AMR during her PhD. While identifying potential vaccine candidates against a pig pathogen, she became acutely cognisant of AMR’s growing health and economic burden in the animal, environmental and human sectors. Eager to get a better grasp on what is an incredibly complex issue, she subsequently moved into genomics.

    Veronica works closely with our industry partners to develop PhD programs focused on broadening our understanding of AMR transmission dynamics. She also spends her days analysing vast collections of whole genome sequences, which have been derived from environmental and animal-associated bacteria – mainly E. coli. More specifically, she’s hard at work investigating the relationships between bacteria from different sources and the mechanisms that drive antimicrobial resistance and pathogen evolution.

    • Academic
    • Masters Research or PhD student supervision
    Disciplines
    • Enzymes
    • Genomics and transcriptomics
    • Proteomics and intermolecular interactions (excl. medical proteomics)
    • Visiting Fellow
    • Australian Inst Microbiology and Infection (AIMI)
    • Visiting FellowAustralian Inst Microbiology and Infection (AIMI)

    Dr Yan Liao is an honorary research fellow at UTS and leads a research group focused on Archaeal Cell Biology and Biotechnology. Her research investigates the molecular mechanisms archaeal cells use for survival, adaptation, interaction, and division, spanning scales from intracellular single-cell processes to ecological community dynamics. Archaea are among the most ancient and resilient forms of life on Earth, and understanding how they function provides key insights into the evolution of cellular life while uncovering new opportunities for biotechnology. Her work integrates advanced approaches including gene and genome editing, protein expression and purification, proteomics, genomics, super-resolution fluorescence microscopy, and electron microscopy.

     

    Dr Liao has published in several prestigious journals, including Nature Microbiology, Nature Communications, and mBio. She has presented her work at international conferences, delivered invited lectures, and established a number of international research collaborations.

     

    Beyond her academic research, Dr Liao is actively involved in science communication and public engagement. She has participated as an invited speaker at high-profile outreach events including Soapbox Science, the Powerhouse Science Festival, Science Meets Parliament, Future Science Talk, and the Science Comedy Program, promoting public awareness of the role of microorganisms in human and environmental health. 

     

    For research collaborations or supervision enquiries, please contact Dr. Liao via her University of Nottingham (UK) profile. 

     

    Dr Yan Liao is an honorary research fellow at UTS and leads a research group focused on Archaeal Cell Biology and Biotechnology. Her research investigates the molecular mechanisms archaeal cells use for survival, adaptation, interaction, and division, spanning scales from intracellular single-cell processes to ecological community dynamics. Archaea are among the most ancient and resilient forms of life on Earth, and understanding how they function provides key insights into the evolution of cellular life while uncovering new opportunities for biotechnology. Her work integrates advanced approaches including gene and genome editing, protein expression and purification, proteomics, genomics, super-resolution fluorescence microscopy, and electron microscopy.

     

    Dr Liao has published in several prestigious journals, including Nature Microbiology, Nature Communications, and mBio. She has presented her work at international conferences, delivered invited lectures, and established a number of international research collaborations.

     

    Beyond her academic research, Dr Liao is actively involved in science communication and public engagement. She has participated as an invited speaker at high-profile outreach events including Soapbox Science, the Powerhouse Science Festival, Science Meets Parliament, Future Science Talk, and the Science Comedy Program, promoting public awareness of the role of microorganisms in human and environmental health. 

     

    For research collaborations or supervision enquiries, please contact Dr. Liao via her University of Nottingham (UK) profile. 

     

    • Academic
    • Masters Research or PhD student supervision
    Disciplines
    • Biochemistry and cell biology
    • Microbiology
    • Visiting Professor
    • Australian Inst Microbiology and Infection (AIMI)
    • Visiting ProfessorAustralian Inst Microbiology and Infection (AIMI)
    Professor Diane McDougald leads the Microbial Ecology and Evolution group located at the Australian Institute for Microbiology & Infection, University of Technology Sydney. Prof McDougald has made significant contributions to the fields of Vibrio biology, bacterial adaptation to stress and mechanisms of molecular control of these responses, cell-to-cell communication, biofilm formation and interactions of bacteria with higher eukaryotes.

    Diane McDougald has over 20 years experience investigating mechanisms of survival and persistence of pathogens in the environment. Outcomes of her research were instrumental in establishing the Biofilm Fundamentals Program in the Environmental Biotechnology Cooperative Research Centre. She led the Marine Health and Biotechnology Program in the Advanced Environmental Biotechnology Centre at Nanyang Technological University (NTU) in Singapore (2009 - 2013) and the Bacterial/Eukaryote Interactions Program in the Singapore Centre for Environmental Life Sciences Engineering at NTU (2013-2021). PhD students she has supervised have gone on to positions in academia and in the water/wastewater industry.
    Professor Diane McDougald leads the Microbial Ecology and Evolution group located at the Australian Institute for Microbiology & Infection, University of Technology Sydney. Prof McDougald has made significant contributions to the fields of Vibrio biology, bacterial adaptation to stress and mechanisms of molecular control of these responses, cell-to-cell communication, biofilm formation and interactions of bacteria with higher eukaryotes.

    Diane McDougald has over 20 years experience investigating mechanisms of survival and persistence of pathogens in the environment. Outcomes of her research were instrumental in establishing the Biofilm Fundamentals Program in the Environmental Biotechnology Cooperative Research Centre. She led the Marine Health and Biotechnology Program in the Advanced Environmental Biotechnology Centre at Nanyang Technological University (NTU) in Singapore (2009 - 2013) and the Bacterial/Eukaryote Interactions Program in the Singapore Centre for Environmental Life Sciences Engineering at NTU (2013-2021). PhD students she has supervised have gone on to positions in academia and in the water/wastewater industry.
    • Academic
    • Masters Research or PhD student supervision
    Disciplines
    • Bacteriology
    • Infectious agents
    • Microbial ecology
    • Microbial genetics
    • Microbiology
    • Chancellor's Research Fellow
    • Medical Science Discipline
    • Chancellor's Research FellowMedical Science Discipline

    Dr Daniel Mediati is a Chancellor's Research Fellow whose research is driven by a commitment to uncovering the molecular principles that govern bacterial adaptation and evolution, and translating these discoveries into new ways of understanding, preventing, and treating infectious disease. He believes that understanding the fundamental mechanisms in microbiology are essential to addressing some of the most pressing challenges in human health.

     

    Daniel is the RNA Regulation and Therapeutics Discipline Lead within the Australian Institute for Microbiology and Infection, where he leads a research group investigating the molecular mechanisms of gene regulation across bacterial systems. His research combines fundamental mechanistic discovery with translational goals. By drawing on both Gram-negative and Gram-positive models, including clinically important pathogens, his group seeks to uncover biological principles with broad implications for microbiology, antimicrobial resistance, and therapeutic development.

     

    Beyond research, Daniel is committed to developing the next generation of scientists and advancing the role of education in scientific discovery. He is a Lecturer within the School of Life Sciences, where he coordinates the undergraduate core subject Molecular Biology (91132) within the Bachelor of Science stream and serves as Program Director of the Master of Medical Biotechnology (C04390). His commitment to innovative, research-informed education has been recognised through a Vice-Chancellor's Learning and Teaching Award.

     

    Daniel also contributes to the broader scientific community through his service on the Board of the Australian Society for Microbiology, NSW-ACT Branch (2023–present).

    Dr Daniel Mediati is a Chancellor's Research Fellow whose research is driven by a commitment to uncovering the molecular principles that govern bacterial adaptation and evolution, and translating these discoveries into new ways of understanding, preventing, and treating infectious disease. He believes that understanding the fundamental mechanisms in microbiology are essential to addressing some of the most pressing challenges in human health.

     

    Daniel is the RNA Regulation and Therapeutics Discipline Lead within the Australian Institute for Microbiology and Infection, where he leads a research group investigating the molecular mechanisms of gene regulation across bacterial systems. His research combines fundamental mechanistic discovery with translational goals. By drawing on both Gram-negative and Gram-positive models, including clinically important pathogens, his group seeks to uncover biological principles with broad implications for microbiology, antimicrobial resistance, and therapeutic development.

     

    Beyond research, Daniel is committed to developing the next generation of scientists and advancing the role of education in scientific discovery. He is a Lecturer within the School of Life Sciences, where he coordinates the undergraduate core subject Molecular Biology (91132) within the Bachelor of Science stream and serves as Program Director of the Master of Medical Biotechnology (C04390). His commitment to innovative, research-informed education has been recognised through a Vice-Chancellor's Learning and Teaching Award.

     

    Daniel also contributes to the broader scientific community through his service on the Board of the Australian Society for Microbiology, NSW-ACT Branch (2023–present).

    • Academic
    • Collaborative projects
    • Masters Research or PhD student supervision
    • Media enquiries
    • Visiting Professor
    • School of Life Sciences
    • Visiting ProfessorSchool of Life Sciences
    Garry Myers is the Director of the Australian Institute for Microbiology & Infection (AIMI, formerly the iThree Institute) at the University of Technology Sydney (UTS).

    He completed his PhD on chlamydial biology in 1998 at the University of Sydney (Faculty of Medicine) via the Menzies School of Health Research (Darwin, NT). He did postdoctoral training at The Institute for Genome Research (TIGR) in Rockville, Maryland, working on microbial genomics and pathogenesis, with numerous high-impact publications, including Science, Nature Biotechnology and Genome Research.

    In 2005 he was invited to join the TIGR Faculty. In 2007, along with twelve other TIGR Faculty, he was a co-founder of the Institute for Genome Sciences at the University of Maryland School of Medicine (Baltimore, Maryland).

    In June 2014, he relocated to the iThree Institute at the University of Technology Sydney; in 2019 he was appointed the Director of the Institute, and is also co-leading the AusGEM initiative (www.ausgem.net).
    Garry Myers is the Director of the Australian Institute for Microbiology & Infection (AIMI, formerly the iThree Institute) at the University of Technology Sydney (UTS).

    He completed his PhD on chlamydial biology in 1998 at the University of Sydney (Faculty of Medicine) via the Menzies School of Health Research (Darwin, NT). He did postdoctoral training at The Institute for Genome Research (TIGR) in Rockville, Maryland, working on microbial genomics and pathogenesis, with numerous high-impact publications, including Science, Nature Biotechnology and Genome Research.

    In 2005 he was invited to join the TIGR Faculty. In 2007, along with twelve other TIGR Faculty, he was a co-founder of the Institute for Genome Sciences at the University of Maryland School of Medicine (Baltimore, Maryland).

    In June 2014, he relocated to the iThree Institute at the University of Technology Sydney; in 2019 he was appointed the Director of the Institute, and is also co-leading the AusGEM initiative (www.ausgem.net).
    • 3 Good Health and Well Being
    • 9 Industry, Innovation and Infrastructure
    • Academic
    • Masters Research or PhD student supervision
    Disciplines
    • Genetics
    • Microbiology
    • Genomics and transcriptomics
    • Research Fellow
    • Medical Science Discipline
    • Research FellowMedical Science Discipline
    Parisa is a research-intensive Post-Doctoral Associate at the Australian Institute for Microbiology & Infection (AIMI), specialising in the field of microbiology. She was awarded her PhD for research on the molecular mechanisms of evolution of pathogenicity in marine bacteria from the University of New South Wales. She has since joined the Australian Institute for Microbiology & Infection (AIMI) in University of Technology Sydney. Parisa’s research focuses on development of diagnostic tools and preventive measures for catheter associated urinary tract infections (CAUTIs). Her work encompasses both management of a multi-site longitudinal observation study on CAUTIs in people with spinal cord injury (SCI) as well as building a catheter biofilm model to test novel prevention and treatment measures.
    Parisa is a research-intensive Post-Doctoral Associate at the Australian Institute for Microbiology & Infection (AIMI), specialising in the field of microbiology. She was awarded her PhD for research on the molecular mechanisms of evolution of pathogenicity in marine bacteria from the University of New South Wales. She has since joined the Australian Institute for Microbiology & Infection (AIMI) in University of Technology Sydney. Parisa’s research focuses on development of diagnostic tools and preventive measures for catheter associated urinary tract infections (CAUTIs). Her work encompasses both management of a multi-site longitudinal observation study on CAUTIs in people with spinal cord injury (SCI) as well as building a catheter biofilm model to test novel prevention and treatment measures.
    • Academic
    • Masters Research or PhD student supervision
    • Collaborative projects
    • Membership of an advisory committee
    • Mentoring (short-term)
    • Mentoring (long-term)
    • Join a web conference as a panellist or speaker
    Disciplines
    • Microbiology
    • Biomedical and clinical sciences
    • Professor
    • Molecular Biotechnology Discipline
    • ProfessorMolecular Biotechnology Discipline

    Associate Professor Matt Padula, while being an Associate Professor in the School of Life Sciences, also operates the Proteomics Core Facility, the main purpose of which is to provide high level technical support and the instrumentation required for researchers to perform their research projects without having to spend long periods of time learning the complicated techniques and instruments needed to answer the scientific question they want answered. The Core is equipped with the knowledge, expertise and instrumentation to perform almost all proteomic, protein chemistry, lipidomic and metabolomic experiments that could be of use to the faculty's researchers. In addition, Core staff have built relationships with other institutions and research groups to gain access to instrumentation and expertise not available within UTS.

    I have 25 years experience in protein chemistry, liquid chromatography, mass spectrometry analysis and characterization of peptides and proteins by liquid chromatography/mass spectrometry (LC/MS), electrophoresis and sample preparation by native and denaturing methodologies. In this time I have performed protein extraction, fractionation and analysis on organisms such as Mycoplasma, bacteria, yeast, mammalian tissue and cells, plant tissue, parasites including Fasciola, Toxoplasma, Eimeria, Haemonchus and Plasmodium, paralysis ticks, coral, snake venom and the pathogenic fungus Cryptococcus. I have expertise in nanoelectrospray mass spectrometric analysis of peptides and proteins, the quantitation of peptides and proteins using mass spectrometry and the determination of de novo peptide sequence from tandem mass spectrometry data.

    In addition, he has expertise in the fractionation of peptides and proteins by analytical and preparative liquid chromatography and analytical and preparative electrophoresis techniques such as 1D and 2D-PAGE, liquid phase isoelectric focusing and continuous elution electrophoresis.

    Recently, the focus of my interests has expanded to include lipids and metabolites, specifically developing methods and techniques to extract and fractionate these molecules, subject them to mass spectrometry for identification and quantification, and perform bioinformatic analysis to determine whether changes in abundance in these molecules is significant.

     

    A note to International students: If you are contacting me about positions in my lab, please don't unless you can secure a scholarship from your home country. If you want my support for scholarship applications in your home country, please contact me with information.

    Associate Professor Matt Padula, while being an Associate Professor in the School of Life Sciences, also operates the Proteomics Core Facility, the main purpose of which is to provide high level technical support and the instrumentation required for researchers to perform their research projects without having to spend long periods of time learning the complicated techniques and instruments needed to answer the scientific question they want answered. The Core is equipped with the knowledge, expertise and instrumentation to perform almost all proteomic, protein chemistry, lipidomic and metabolomic experiments that could be of use to the faculty's researchers. In addition, Core staff have built relationships with other institutions and research groups to gain access to instrumentation and expertise not available within UTS.

    I have 25 years experience in protein chemistry, liquid chromatography, mass spectrometry analysis and characterization of peptides and proteins by liquid chromatography/mass spectrometry (LC/MS), electrophoresis and sample preparation by native and denaturing methodologies. In this time I have performed protein extraction, fractionation and analysis on organisms such as Mycoplasma, bacteria, yeast, mammalian tissue and cells, plant tissue, parasites including Fasciola, Toxoplasma, Eimeria, Haemonchus and Plasmodium, paralysis ticks, coral, snake venom and the pathogenic fungus Cryptococcus. I have expertise in nanoelectrospray mass spectrometric analysis of peptides and proteins, the quantitation of peptides and proteins using mass spectrometry and the determination of de novo peptide sequence from tandem mass spectrometry data.

    In addition, he has expertise in the fractionation of peptides and proteins by analytical and preparative liquid chromatography and analytical and preparative electrophoresis techniques such as 1D and 2D-PAGE, liquid phase isoelectric focusing and continuous elution electrophoresis.

    Recently, the focus of my interests has expanded to include lipids and metabolites, specifically developing methods and techniques to extract and fractionate these molecules, subject them to mass spectrometry for identification and quantification, and perform bioinformatic analysis to determine whether changes in abundance in these molecules is significant.

     

    A note to International students: If you are contacting me about positions in my lab, please don't unless you can secure a scholarship from your home country. If you want my support for scholarship applications in your home country, please contact me with information.

    • 3 Good Health and Well Being
    • 9 Industry, Innovation and Infrastructure
    • Academic
    • Masters Research or PhD student supervision
    • Career advice
    • Collaborative projects
    • Industry Projects
    • Join a web conference as a panellist or speaker
    • Media enquiries
    • Membership of an advisory committee
    • Mentoring (long-term)
    • Mentoring (short-term)
    • Technical support
    Disciplines
    • Biochemistry and cell biology
    • Medical biochemistry and metabolomics
    • Proteomics and intermolecular interactions (excl. medical proteomics)
    • Proteomics and metabolomics
    • Medical biochemistry - proteins and peptides (incl. medical proteomics)
    • Visiting Fellow
    • Australian Inst Microbiology and Infection (AIMI)
    • Visiting FellowAustralian Inst Microbiology and Infection (AIMI)

    Miranda joined AIMI in 2023 as an AIMI Pathway Fellow. Miranda completed her PhD at the Institute for Molecular Bioscience (University of Queensland). This research delved into understanding the mode of action of last line antibiotics against multidrug-resistant Gram-negative bacteria and identifying the genetic basis underpinning resistance. From 2019 to 2023, Miranda was a Postdoctoral Researcher at the Peter Doherty Institute for Infection and Immunity (University of Melbourne). Her research primarily focuses on antimicrobial resistance, bacterial genomics and transcriptomics.

    Miranda joined AIMI in 2023 as an AIMI Pathway Fellow. Miranda completed her PhD at the Institute for Molecular Bioscience (University of Queensland). This research delved into understanding the mode of action of last line antibiotics against multidrug-resistant Gram-negative bacteria and identifying the genetic basis underpinning resistance. From 2019 to 2023, Miranda was a Postdoctoral Researcher at the Peter Doherty Institute for Infection and Immunity (University of Melbourne). Her research primarily focuses on antimicrobial resistance, bacterial genomics and transcriptomics.

    • Academic
    • Visiting Professor
    • Australian Inst Microbiology and Infection (AIMI)
    • Visiting ProfessorAustralian Inst Microbiology and Infection (AIMI)
    A/Prof. Rice’s research programme is centered on how and why bacteria form matrix encased biofilms. The goal of such research is to define the molecular pathways that control the biofilm life-cycle, with a particular interest in those processes that regulate the switch between planktonic and biofilm growth. Such knowledge can be used to manipulate the biofilm in a directed fashion to either encourage or discourage biofilm formation as needed.
    A/Prof. Rice’s research programme is centered on how and why bacteria form matrix encased biofilms. The goal of such research is to define the molecular pathways that control the biofilm life-cycle, with a particular interest in those processes that regulate the switch between planktonic and biofilm growth. Such knowledge can be used to manipulate the biofilm in a directed fashion to either encourage or discourage biofilm formation as needed.
    • Academic
    • Visiting Fellow
    • Australian Inst Microbiology and Infection (AIMI)
    • Visiting FellowAustralian Inst Microbiology and Infection (AIMI)

    Dr. Piklu Roy Chowdhury (née: Piklu Bhattacharya) serves as a senior research fellow and a research-focused academic at the Australian Institute for Microbiology and Infection (AIMI), which is a part of the University of Technology Sydney's Faculty of Science. With expertise in both clinical and molecular microbiology, she addresses complex challenges in public health epidemiology and the emergence of various drug-resistant pathogens through the application of multi-omics approaches. Her research primarily seeks to generate a comprehensive understanding of infection mechanisms and host responses, with the overarching aim of developing diagnostic and preventative tools.

     

    Trained as a molecular microbiologist at the University of Canterbury in New Zealand, she has years of experience in analysing human and animal pathogens' genomes, transcriptomes, and proteomes. Her research outputs demonstrate her expertise in investigating factors that influence host-pathogen interactions, both synergistic and antagonistic; the role of bacterial secretion systems in pathogenesis; and the impacts of lateral gene transfer on the evolution of multi-drug-resistant pathogen genomes.

    Dr. Piklu Roy Chowdhury (née: Piklu Bhattacharya) serves as a senior research fellow and a research-focused academic at the Australian Institute for Microbiology and Infection (AIMI), which is a part of the University of Technology Sydney's Faculty of Science. With expertise in both clinical and molecular microbiology, she addresses complex challenges in public health epidemiology and the emergence of various drug-resistant pathogens through the application of multi-omics approaches. Her research primarily seeks to generate a comprehensive understanding of infection mechanisms and host responses, with the overarching aim of developing diagnostic and preventative tools.

     

    Trained as a molecular microbiologist at the University of Canterbury in New Zealand, she has years of experience in analysing human and animal pathogens' genomes, transcriptomes, and proteomes. Her research outputs demonstrate her expertise in investigating factors that influence host-pathogen interactions, both synergistic and antagonistic; the role of bacterial secretion systems in pathogenesis; and the impacts of lateral gene transfer on the evolution of multi-drug-resistant pathogen genomes.

    • Academic
    • Masters Research or PhD student supervision
    Disciplines
    • Genetics
    • Microbiology
    • Associate Professor
    • Medical Science Discipline
    • Associate ProfessorMedical Science Discipline

    Biography

    I am a cellular immunologist specialising in infectious and inflammatory diseases, with a focus on understanding host immune responses and translating this knowledge into new diagnostics, therapies, and vaccines. My work spans basic immunology through to biomarker discovery, and the development of new vaccines and therapeutics development.

    A major focus of my research is tuberculosis (TB) and non‑tuberculous mycobacterial (NTM) diseases, including Mycobacterium avium. Despite the availability of antibiotics, these diseases remain major global health challenges. My research aims to address critical gaps in diagnosis and disease monitoring by identifying biomarkers that can improve TB diagnosis and enable monitoring of response to therapy.

    My group investigates the mechanisms that govern macrophage function, with a particular interest in how microRNAs modulate immune responses and contribute to disease pathogenesis.

    In parallel, I lead research into new therapies for mycobacterial diseases This work involves testing novel interventions, using advanced in vitro and in vivo systems,  including development of human 3D organ models to better capture disease processes.

    One example is lymphangioleiomyomatosis (LAM), a rare lung disease characterised by destructive cystic lesions and limited treatment options. Rapamycin is currently the only approved therapy, and not all patients respond. My group is working with colleagues at UTS to develop human lung organ models of LAM to better understand disease mechanisms and to test new therapeutic approaches in a physiologically relevant system.

    I also have active collaborations at UTS focused on next‑generation vaccine development. This includes investigating host immune responses to novel mRNA and nanotechnology‑based vaccines for infectious diseases such as TB, as well as preventative vaccine strategies targeting Alzheimer’s disease. These projects aim to better understand vaccine‑induced immunity and support the development of innovative platforms with broad translational potential.

    Overall, my research program integrates immunology, genomics, bioengineering, and clinical collaboration to address major unmet needs in infectious and inflammatory diseases, with a strong commitment to translation, international collaboration, and research training.

    Biography

    I am a cellular immunologist specialising in infectious and inflammatory diseases, with a focus on understanding host immune responses and translating this knowledge into new diagnostics, therapies, and vaccines. My work spans basic immunology through to biomarker discovery, and the development of new vaccines and therapeutics development.

    A major focus of my research is tuberculosis (TB) and non‑tuberculous mycobacterial (NTM) diseases, including Mycobacterium avium. Despite the availability of antibiotics, these diseases remain major global health challenges. My research aims to address critical gaps in diagnosis and disease monitoring by identifying biomarkers that can improve TB diagnosis and enable monitoring of response to therapy.

    My group investigates the mechanisms that govern macrophage function, with a particular interest in how microRNAs modulate immune responses and contribute to disease pathogenesis.

    In parallel, I lead research into new therapies for mycobacterial diseases This work involves testing novel interventions, using advanced in vitro and in vivo systems,  including development of human 3D organ models to better capture disease processes.

    One example is lymphangioleiomyomatosis (LAM), a rare lung disease characterised by destructive cystic lesions and limited treatment options. Rapamycin is currently the only approved therapy, and not all patients respond. My group is working with colleagues at UTS to develop human lung organ models of LAM to better understand disease mechanisms and to test new therapeutic approaches in a physiologically relevant system.

    I also have active collaborations at UTS focused on next‑generation vaccine development. This includes investigating host immune responses to novel mRNA and nanotechnology‑based vaccines for infectious diseases such as TB, as well as preventative vaccine strategies targeting Alzheimer’s disease. These projects aim to better understand vaccine‑induced immunity and support the development of innovative platforms with broad translational potential.

    Overall, my research program integrates immunology, genomics, bioengineering, and clinical collaboration to address major unmet needs in infectious and inflammatory diseases, with a strong commitment to translation, international collaboration, and research training.

    • Academic
    • Masters Research or PhD student supervision
    Disciplines
    • Immunology
    • Microbiology
    • Future Fellow
    • Molecular Biotechnology Discipline
    • Future FellowMolecular Biotechnology Discipline

    ARC Future Fellow Dr. Bill Söderström leads the Microbial Super-Resolution Microscopy Lab (soderstromlab.com) at the Australian Institute for Microbiology and Infection, AIMI , where he also serves as the Institute Lead for ECR Development and Inclusion. Since 2022, Bill has secured more than $3 million AUD in funding (including from ARC and MRFF) to support his research. He is a Fellow of the Australian Society for Microbiology (FASM). 

    With a background in Biomedical physics, Bill uses advanced imaging techniques and genetics in combination with microfluidic-based approaches to better understand bacterial morphology changes during stress conditions. Research in his lab is primarily focused on how bacterial cells go about dividing and multiplying during Urinary Tract Infections (UTIs). In this way, he wants to identify new ways to inhibit division, with the rationale that if the bacteria cannot divide, they cannot spread infection.

    He obtained his doctoral degree in Biophysics at Stockholm University in 2014 under the joint supervision of Profs. Gunnar von Heijne and Daniel Daley. He later took up a postdoctoral scholar position at the Okinawa Institute of Science and Technology (OIST) in Japan, to further study bacterial cell division. At OIST he developed approaches in Correlative cryo-Light and cryo-Electron Microscopy (Cryo-CLEM). He also pioneered ways to image bacteria in a vertical position using micron holes, that in combination with super-resolution fluorescence microscopy, provide superior resolution of the protein complexes in live bacteria.

    His work on these topics has received multiple recommendations in the Faculty of 1000, is frequently mentioned in popular media, on Wikipedia and in patents, and is regularly highlighted in review articles.

    Bill also holds a Master of Science degree in Engineering Physics from the Royal Institute of Technology, KTH, in an interdisciplinary program with the Karolinska Institute (KI), both in Stockholm, Sweden. He focused on the physics of clinically used medical imaging systems such as Positron Emission Tomography (PET), Magnetic Resonance Imagining (MRI) and Ultrasound.

    ARC Future Fellow Dr. Bill Söderström leads the Microbial Super-Resolution Microscopy Lab (soderstromlab.com) at the Australian Institute for Microbiology and Infection, AIMI , where he also serves as the Institute Lead for ECR Development and Inclusion. Since 2022, Bill has secured more than $3 million AUD in funding (including from ARC and MRFF) to support his research. He is a Fellow of the Australian Society for Microbiology (FASM). 

    With a background in Biomedical physics, Bill uses advanced imaging techniques and genetics in combination with microfluidic-based approaches to better understand bacterial morphology changes during stress conditions. Research in his lab is primarily focused on how bacterial cells go about dividing and multiplying during Urinary Tract Infections (UTIs). In this way, he wants to identify new ways to inhibit division, with the rationale that if the bacteria cannot divide, they cannot spread infection.

    He obtained his doctoral degree in Biophysics at Stockholm University in 2014 under the joint supervision of Profs. Gunnar von Heijne and Daniel Daley. He later took up a postdoctoral scholar position at the Okinawa Institute of Science and Technology (OIST) in Japan, to further study bacterial cell division. At OIST he developed approaches in Correlative cryo-Light and cryo-Electron Microscopy (Cryo-CLEM). He also pioneered ways to image bacteria in a vertical position using micron holes, that in combination with super-resolution fluorescence microscopy, provide superior resolution of the protein complexes in live bacteria.

    His work on these topics has received multiple recommendations in the Faculty of 1000, is frequently mentioned in popular media, on Wikipedia and in patents, and is regularly highlighted in review articles.

    Bill also holds a Master of Science degree in Engineering Physics from the Royal Institute of Technology, KTH, in an interdisciplinary program with the Karolinska Institute (KI), both in Stockholm, Sweden. He focused on the physics of clinically used medical imaging systems such as Positron Emission Tomography (PET), Magnetic Resonance Imagining (MRI) and Ultrasound.

    • 4 Quality Education
    • 3 Good Health and Well Being
    • 9 Industry, Innovation and Infrastructure
    • Academic
    • Collaborative projects
    • Masters Research or PhD student supervision
    • Media enquiries
    • Membership of an advisory committee
    Disciplines
    • Bacteriology
    • Biological physics
    • Infectious agents
    • Senior Research Assistant
    • Australian Inst Microbiology and Infection (AIMI)
    • Senior Research AssistantAustralian Inst Microbiology and Infection (AIMI)
    • Professional
    Disciplines
    • Medical microbiology
    • Microbiology